AWM
IMGN

Avior Wealth Management’s Immunogen Inc IMGN Stock Holding History

Avior Wealth Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-185
Closed -$3.68K – 1681
2023
Q3 		$2.94K Hold
185
– – ﹤0.01% 1336
2023
Q2 		$3.49K Buy
+185
New +$2.18K ﹤0.01% 1271
2014
Q2 		– Sell
-300
Closed -$4K – 344
2014
Q1 		$4K Buy
+300
New +$4.73K ﹤0.01% 292

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Avior Wealth Management's IMGN Position: Q4 2023 in Review

Avior Wealth Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 185 shares — an estimated $3.68K sold.

Avior Wealth Management first reported a position in IMGN in Q1 2014 and held it in 3 quarters. The position peaked at $4K in Q1 2014. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Avior Wealth Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Avior Wealth Management sold 185 Immunogen Inc shares in Q4 2023, an estimated $3.68K.
  • Avior Wealth Management first reported a position in Immunogen Inc in Q1 2014 and held it in 3 quarters.
  • Avior Wealth Management's Immunogen Inc position peaked at $4K in Q1 2014.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Avior Wealth Management's 13F filing for Q4 2023, filed 30 Jan 2024.